GC
APYX icon

Guggenheim Capital’s Apyx Medical APYX Stock Holding History

Guggenheim Capital’s Portfolio APYX Stock Details APYX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-37,609
Closed -$111K – 3065
2013
Q2 		$111K Buy
+37,609
New +$126K ﹤0.01% 2812

Other funds holding APYX

Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $171B AUM 24.68% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $177B AUM 39.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Guggenheim Capital's APYX Position: Q3 2013 in Review

Guggenheim Capital sold out of Apyx Medical (APYX) in Q3 2013, closing a stake of 37,609 shares — an estimated $111K sold.

Guggenheim Capital first reported a position in APYX in Q2 2013 and held it in 1 quarter. The position peaked at $111K in Q2 2013. 19 funds tracked by Wall St. Rank hold APYX as of Q3 2013.

  • Guggenheim Capital reported no remaining Apyx Medical position as of Q3 2013 after selling out during the quarter.
  • Guggenheim Capital sold 37,609 Apyx Medical shares in Q3 2013, an estimated $111K.
  • Guggenheim Capital first reported a position in Apyx Medical in Q2 2013 and held it in 1 quarter.
  • Guggenheim Capital's Apyx Medical position peaked at $111K in Q2 2013.
  • 19 funds tracked by Wall St. Rank held Apyx Medical as of Q3 2013.

Based on Guggenheim Capital's 13F filing for Q3 2013, filed 14 Nov 2013.